GFP
CRMD icon

Gryphon Financial Partners’s CorMedix CRMD Stock Holding History

Gryphon Financial Partners’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$236K Buy
30,059
+2,658
+10% +$21K 0.02% 354
2026
Q1 		$186K Buy
27,401
+1,618
+6% +$12K 0.02% 356
2025
Q4 		$300K Buy
+25,783
New +$285K 0.03% 272

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Gryphon Financial Partners's CRMD Position: Q2 2026 in Review

Gryphon Financial Partners increased its CorMedix (CRMD) stake by 9.7% in Q2 2026, buying an estimated $21K and bringing the position to 30,059 shares worth $236K. The position accounts for 0.02% of the portfolio, ranked #354.

Gryphon Financial Partners first reported a position in CRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $300K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Gryphon Financial Partners held 30,059 shares of CorMedix worth $236K as of Q2 2026.
  • Gryphon Financial Partners bought 2,658 CorMedix shares in Q2 2026, an estimated $21K.
  • CorMedix made up 0.02% of Gryphon Financial Partners's portfolio in Q2 2026, its #354 holding.
  • Gryphon Financial Partners first reported a position in CorMedix in Q4 2025 and has held it in 3 quarters since.
  • Gryphon Financial Partners's CorMedix position peaked at $300K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.